575 Regent Pacific Group Limited HKEX · Hong Kong

Regent Pacific Group (575) news

Regent Pacific Group Limited is a public biotech or pharmaceutical company listed on HKEX under the ticker 575, recorded under Hong Kong. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Regent Pacific Group news

We have not published a story on Regent Pacific Group yet. When there is news, it will appear here.

Questions about Regent Pacific Group

What is the ticker symbol of Regent Pacific Group?

Regent Pacific Group Limited trades under the ticker 575 on HKEX.

Where is Regent Pacific Group listed?

Regent Pacific Group Limited is listed on HKEX.

Which country or territory is Regent Pacific Group listed under?

Our directory records Regent Pacific Group Limited under Hong Kong.

What does Regent Pacific Group do?

Our directory classifies Regent Pacific Group Limited as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Regent Pacific Group?

The ISIN recorded for Regent Pacific Group Limited is KYG3042R1314.

Does aibio.space cover Regent Pacific Group?

aibio.space lists Regent Pacific Group Limited among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Regent Pacific Group?

Companies in our directory listed in the same country and business area as Regent Pacific Group: Extrawell Pharmaceutical Holdings, Beijing Tong Ren Tang Chinese Medicine Co., Sanai Health Industry Group Company, HUTCHMED (China), China Biotech Services Holdings, SSY Group.

Investor discussion: Regent Pacific Group

Members talk about Regent Pacific Group (575). Reader posts, not aibio.space reporting, and not investment advice.

Rules

Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at Regent Pacific Group, newest first. Each line links the filing it comes from.

May 6, 2026Financings
Share or debt issue: (1) Proposed Adoption of The Restricted Share Unit Scheme; (2) Proposed Adoption of Audited Financial Statements; (3) Proposed Re-Appointment of Auditor; (4) Proposals for General Mandates to Issue Shares and to Repurchase Shares; (5) Re-Election of Retiring Directors; and (6) Notice of Annual General Meeting. Source
Jun 25, 2025Financings
Share or debt issue: Completion of Connected Transaction - Loan Capitalisation Involving Issue of New Shares under Specific Mandate. Source
May 15, 2025Financings
Share or debt issue: (1) Connected Transaction - Loan Capitalisation Involving Issue of New Shares Under Specific Mandate and (2) Notice of the Extraordinary General Meeting. Source
Apr 28, 2025Financings
Share or debt issue: (1) Proposals for General Mandates to Issue Shares and to Repurchase Shares; (2) Re-Election of Retiring Directors; and (3) Notice of Annual General Meeting. Source
Apr 7, 2025Financings
Share or debt issue: Connected transaction - Loan capitalisation involving issue of new shares under specific mandate. Source

Press releases

Headlines of Regent Pacific Group's own announcements, newest first. Each opens the full release on the newswire that carried it.

Sep 28, 2026HKEXnews
Voluntary Announcement - Launch of Accrua - Deep Longevity's Consumer Digital Health Platform in the United States
Sep 21, 2026HKEXnews
Notification Letter to Non-registered Shareholders and Request Form
Sep 21, 2026HKEXnews
Notification Letter to Registered Shareholders and Change Request Form
Sep 1, 2026HKEXnews
Voluntary Operational Update - Receipt of Payment from Fosun Wanbang (Jiangsu) Pharmaceutical Group Co., Ltd. and Update on Senstend Commercialisation in the PRC
Aug 25, 2026HKEXnews
Unaudited Interim Results for the Six Months Ended 30 June 2026
Aug 3, 2026HKEXnews
Positive Profit Alert
Jul 9, 2026HKEXnews
Supplementary Announcement to the 2025 Annual Report
Jun 30, 2026HKEXnews
Voluntary Operational Update - New Peer-Reviewed Study Finds Deep Longevity's Blood-Based Biological Age Gap Predicts Mortality and Hospitalization Risk
Jun 25, 2026HKEXnews
Voluntary Operational Update - Deep Longevity Named Runner-Up in Nestle VITAL Smart Aging Global Challenge; AI-powered Biological Aging Platform Recognised Among the World's Top Health Technology Innovators
Jun 16, 2026HKEXnews
Operational Update - Landmark NMPA Approval of Senstend, Marking a Transformational Milestone and Accelerating Commercialisation in China
May 29, 2026HKEXnews
Poll Results of the Annual General Meeting Held on 29 May 2026
May 6, 2026HKEXnews
Rules Relating to The Restricted Share Unit Scheme of Regent Pacific Group Limited
May 6, 2026HKEXnews
Notice of Annual General Meeting
May 6, 2026HKEXnews
(1) Proposed Adoption of The Restricted Share Unit Scheme; (2) Proposed Adoption of Audited Financial Statements; (3) Proposed Re-Appointment of Auditor; (4) Proposals for General Mandates to Issue Shares and to Repurchase Shares; (5) Re-Election of Retiring Directors; and (6) Notice of Annual General Meeting
May 4, 2026HKEXnews
Proposed Adoption of the Restricted Share Unit Scheme
Apr 29, 2026HKEXnews
Notification Letter to Registered Shareholders and Reply Form - Election of Means of Receipt of Corporate Communications
Mar 26, 2026HKEXnews
Audited Final Results for the Year Ended 31 December 2025
Dec 19, 2025HKEXnews
Terms of Reference of the Audit Committee
Dec 10, 2025HKEXnews
Voluntary Operational Update - Deep Longevity's U.S. Expansion with Key Leadership Appointments Ahead of 2026 Launch
Dec 1, 2025HKEXnews
Voluntary Operational Update - Deep Longevity's Strategic U.S. Market Entry in Q1 2026

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open HKEX:575 on TradingView.

Listing details

Company: Regent Pacific Group Limited
Ticker: 575
Listing: HKEX
Country or territory: Hong Kong
Business scope: Pharmaceuticals: Major
ISIN: KYG3042R1314
Last quote in directory: 2026-10-22
Directory source: Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction